Related references
Note: Only part of the references are listed.Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation
Heidi Ehrentraut et al.
PLOS ONE (2012)
Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors
Aleksandra Eric-Nikolic et al.
IMMUNOBIOLOGY (2011)
Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets
Patrick J. Schuler et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Features of responding T cells in cancer and chronic infection
Peter S. Kim et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Secondary immunodeficiencies, including HIV infection
Javier Chinen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adenosine A1 receptor antagonists in clinical research and development
Berthold Hocher
KIDNEY INTERNATIONAL (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Magis Mandapathil et al.
CLINICAL CANCER RESEARCH (2009)
Regulatory T cells and autoimmunity
Josephine Vila et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV
Nuria Climent et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Extracellular 2′,3′-cAMP Is a Source of Adenosine
Edwin K. Jackson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression
Magis Mandapathil et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: Mechanisms of suppression and expansion in advanced disease
Christoph Bergmann et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
Is FOXP3 a bona fide marker for human regulatory T cells?
Maria-Grazia Roncarolo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism
Margaret S. Bynoel et al.
TRENDS IN IMMUNOLOGY (2008)
Immunoregulatory T Cells: Role and Potential as a Target in Malignancy
Marc Beyer et al.
CURRENT ONCOLOGY REPORTS (2008)
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival
Dirk Nagorsen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin
Yusuke Komi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells:: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino et al.
BLOOD (2007)
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling
Tatiana Raskovalova et al.
CANCER RESEARCH (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
NTPDase and 5 '-nucleotidase activities in physiological and disease conditions: New perspectives for human health
Maria Rosa C. Schetinger et al.
BIOFACTORS (2007)
Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26
Annemie Van Linden et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells
Anna Lokshin et al.
CANCER RESEARCH (2006)
GS protein-coupled adenosine receptor signaling and lytic function of activated NK cells
T Raskovalova et al.
JOURNAL OF IMMUNOLOGY (2005)
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?
MV Sitkovsky et al.
TRENDS IN IMMUNOLOGY (2005)
Adenosine receptors: G protein-mediated signalling and the role of accessory proteins
M Klinger et al.
CELLULAR SIGNALLING (2002)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage
A Ohta et al.
NATURE (2001)
Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood
D Dieckmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The binding site of human adenosine deaminase for CD26/dipeptidyl peptidase IV: The Arg142Gln mutation impairs binding to CD26 but does not cause immune deficiency
E Richard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)